Park Avenue Securities LLC bought a new position in shares of Vivmark Residential Common Shares of Beneficial Interest (NYSE:VMRK – Free Report) in the 3rd quarter, Holdings Channel.com reports. The institutional investor bought 20,284 shares of the company’s stock, valued at approximately $1,232,000.
Other institutional investors have also made changes to their positions in the company. Ferguson Wellman Capital Management Inc. bought a new stake in Vivmark Residential Common Shares of Beneficial Interest in the 3rd quarter valued at $42,080,000. Robeco Institutional Asset Management B.V. bought a new position in Vivmark Residential Common Shares of Beneficial Interest during the third quarter worth $41,636,000. Fort Washington Investment Advisors Inc. OH bought a new position in Vivmark Residential Common Shares of Beneficial Interest during the third quarter worth $38,810,000. State of Alaska Department of Revenue acquired a new position in shares of Vivmark Residential Common Shares of Beneficial Interest in the third quarter valued at $27,330,000. Finally, Perpetual Ltd acquired a new position in shares of Vivmark Residential Common Shares of Beneficial Interest in the third quarter valued at $26,651,000. 92.68% of the stock is owned by institutional investors and hedge funds.
Insiders Place Their Bets
In related news, Director Susan Swanezy sold 15,700 shares of the company’s stock in a transaction dated Tuesday, August 18th. The shares were sold at an average price of $63.80, for a total value of $1,001,660.00. Following the transaction, the director directly owned 28,934 shares in the company, valued at approximately $1,845,989.20. This represents a 35.17% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, Director Charles E. Mueller, Jr. sold 8,000 shares of the firm’s stock in a transaction dated Tuesday, August 18th. The stock was sold at an average price of $63.90, for a total transaction of $511,200.00. Following the transaction, the director directly owned 16,084 shares in the company, valued at approximately $1,027,767.60. This represents a 33.22% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders sold a total of 58,286 shares of company stock valued at $3,735,822 in the last three months. Insiders own 1.20% of the company’s stock.
Wall Street Analyst Weigh In
VMRK has been the subject of a number of research reports. Stifel Nicolaus cut their target price on shares of Vivmark Residential Common Shares of Beneficial Interest from $79.00 to $78.50 and set a “buy” rating for the company in a research note on Wednesday, August 19th. Morgan Stanley started coverage on shares of Vivmark Residential Common Shares of Beneficial Interest in a research note on Tuesday, August 25th. They issued an “overweight” rating and a $75.00 price target on the stock. Wells Fargo & Company decreased their price target on shares of Vivmark Residential Common Shares of Beneficial Interest from $72.00 to $68.00 and set an “overweight” rating on the stock in a research note on Monday, October 19th. Mizuho raised shares of Vivmark Residential Common Shares of Beneficial Interest from a “neutral” rating to an “outperform” rating and increased their price target for the company from $70.00 to $73.00 in a report on Tuesday, September 8th. Finally, Weiss Ratings started coverage on shares of Vivmark Residential Common Shares of Beneficial Interest in a research report on Wednesday, August 19th. They set a “hold (c)” rating for the company. Five investment analysts have rated the stock with a Buy rating and eleven have issued a Hold rating to the company. According to MarketBeat.com, Vivmark Residential Common Shares of Beneficial Interest currently has a consensus rating of “Hold” and a consensus target price of $71.42.
Read Our Latest Stock Report on Vivmark Residential Common Shares of Beneficial Interest
Vivmark Residential Common Shares of Beneficial Interest Price Performance
VMRK opened at $62.25 on Tuesday. The company has a debt-to-equity ratio of 0.77, a current ratio of 0.19 and a quick ratio of 0.19. The firm has a fifty day moving average price of $62.83. Vivmark Residential Common Shares of Beneficial Interest has a 1 year low of $57.57 and a 1 year high of $71.50. The company has a market cap of $23.34 billion, a P/E ratio of 26.14, a PEG ratio of 3.53 and a beta of 0.74.
Vivmark Residential Common Shares of Beneficial Interest (NYSE:VMRK – Get Free Report) last posted its quarterly earnings data on Wednesday, July 22nd. The company reported $0.30 earnings per share for the quarter. The firm had revenue of $785.05 million for the quarter. Vivmark Residential Common Shares of Beneficial Interest had a return on equity of 8.06% and a net margin of 27.97%. Equities analysts anticipate that Vivmark Residential Common Shares of Beneficial Interest will post 4.07 earnings per share for the current fiscal year.
Vivmark Residential Common Shares of Beneficial Interest Announces Dividend
The firm also recently announced a quarterly dividend, which was paid on Friday, October 16th. Stockholders of record on Monday, October 5th were given a $0.7025 dividend. This represents a $2.81 dividend on an annualized basis and a dividend yield of 4.5%. The ex-dividend date of this dividend was Monday, October 5th. Vivmark Residential Common Shares of Beneficial Interest’s payout ratio is presently 122.17%.
Vivmark Residential Common Shares of Beneficial Interest Company Profile
Equity Residential is committed to creating communities where people thrive. The Company, a member of the S&P 500, is focused on the acquisition, development and management of residential properties located in and around dynamic cities that attract high quality long-term renters. Equity Residential owns or has investments in 305 properties consisting of 78,568 apartment units, located in Boston, New York, Washington, DC, Seattle, San Francisco, Southern California and Denver.
Read More
- Five stocks we like better than Vivmark Residential Common Shares of Beneficial Interest
- AbbVie’s Humira Era Is Fading, But Its New Growth Engines Face Another Test
- GLP-1 Focus or Broader Peptide Exposure: Which ETF Has the Edge?
- Mortgage Rates Froze U.S. Housing, But These 3 Overseas Markets Still Pay Double Digits
- Big Tech Is Spending Billions on AIāThese 5 Stocks Are Getting Paid
Want to see what other hedge funds are holding VMRK? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Vivmark Residential Common Shares of Beneficial Interest (NYSE:VMRK – Free Report).
Receive News & Ratings for Vivmark Residential Common Shares of Beneficial Interest Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vivmark Residential Common Shares of Beneficial Interest and related companies with MarketBeat.com's FREE daily email newsletter.
